Bergen Brunswig and PharMerica Named as Defendants in Lawsuit.ORANGE, Calif.--(BUSINESS WIRE)--April 16, 1999-- Bergen Brunswig Corporation (NYSE NYSE See: New York Stock Exchange :BBC BBC in full British Broadcasting Corp. Publicly financed broadcasting system in Britain. A private company at its founding in 1922, it was replaced by a public corporation under royal charter in 1927. ) and PharMerica, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DOSE) stated that Bergen and PharMerica were named as defendants in a lawsuit commenced on April 14, 1999 by PMR PMR 1 Percutaneous myocardial revascularization, see there 2 Perinatal mortality rate 3 Polymyalgia rheumatica 4 Proportionate mortality ratio, see there Corp. in the Superior Court of California, San Diego County. The complaint seeks, among other things, an injunction enjoining en·join tr.v. en·joined, en·join·ing, en·joins 1. To direct or impose with authority and emphasis. 2. To prohibit or forbid. See Synonyms at forbid. Bergen Brunswig from closing its proposed acquisition of PharMerica and general, special and punitive damages Monetary compensation awarded to an injured party that goes beyond that which is necessary to compensate the individual for losses and that is intended to punish the wrongdoer. relating to alleged breaches of an agreement between PMR and a Bergen subsidiary. Bergen and PharMerica believe that PMR's claims are without merit and intend to vigorously contest the allegations in PMR's complaint. A hearing with respect to PMR's request for injunctive relief has been scheduled for April 20, 1999. Statements in this press release regarding future events constitute forward-looking statements under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements contained in this press release are subject to certain risks and uncertainties that could cause actual results to differ materially from those implied by such forward-looking statements. For example, because of the uncertainty of all litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , there can be no assurance that Bergen and PharMerica will be successful defending against PMR's lawsuit. Certain additional risks associated with PharMerica and Bergen are set forth in reports that they have filed with the Securities and Exchange Commission, including Bergen's Annual Report on Form 10-K for the year ended September 30, 1998 and PharMerica's Annual Report on Form 10-K for the year ended December 31, 1998. Bergen Brunswig Corporation is one of the nation's leading supply channel management companies, providing pharmaceuticals, medical-surgical and specialty products as well as information management solutions and outsourcing services designed to improve cost-effectiveness and increase value for customers, patients and manufacturers across the entire healthcare spectrum. The company also develops disease-specific treatment protocols and pharmacoeconomic initiatives to assist in the reduction of overall healthcare costs while improving disease management and outcomes. PharMerica, Inc. is a leading provider of pharmaceutical products and services serving approximately 500,000 patients in alternate and long-term care settings. The company provides its services to patients in skilled nursing facilities, assisted living facilities, residential and independent living communities, specialty hospitals and the home setting. PharMerica currently serves approximately 380,000 long-term care residents and more than 106,000 Worker's Compensation patients via mail service and on-line pharmacy. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion